Dermacyte® Matrix

by

An Elegant Clinical Solution to Protect Soft Tissue Defects

Easy to Use
Ready for Application

  • Dehydrated for easy application with no refrigeration
  • No preparation time required for thawing or soaking— reducing operative time

 

Easy to Handle

  • Conforms to wound bed and naturally hydrates in place
  • Superior handling and optimal bioabsorption properties

 

Improved Patient Experience Wound bed protection from the external environment Clinically studied with published literature in real-world uses for safety Simple Wound Monitoring Routine dressing changes, wound cleansing, and Dermacyte reapplication allows for easy assessment of wound closure.

Dermacyte® Matrix is derived from human postpartum amniotic tissues that have been processed to retain native characteristics and are clinically shown to improve outcomes in wound closure when applied as a protective covering

1. Ditmars, F. S., Kay, K. E., Broderick, T. C., & Fagg, W. S. (2024). Use of amniotic membrane in hard-to-heal wounds: a multicentre retrospective study. Journal of wound care, 33(Sup3), S44-S50.

Additional Resources:

Want More Information?

All information provided is for educational use only.  Information is deemed accurate, but user is encouraged to verify independently.

Contact Us